Blockchain Registration Transaction Record

Helus Pharma Appoints Industry Veteran Dr. Freda Lewis-Hall to Board

Helus Pharma appoints Dr. Freda Lewis-Hall to its board to advance novel mental health treatments. Learn how her expertise aims to improve therapies for depression and anxiety.

This appointment is crucial because it brings decades of top-tier pharmaceutical and psychiatric expertise to Helus Pharma at a pivotal moment. Dr. Lewis-Hall's background at major companies like Pfizer and her regulatory experience can accelerate the development of novel treatments for depression and anxiety, conditions affecting millions globally. With mental health crises rising and existing treatments often inadequate, her leadership could help bring breakthrough therapies to market faster, potentially transforming patient care and addressing a significant public health need.